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stereotatic patients. Currently, intra-fraction deviations 
observed in clinical practice are being analysed with the aim 
of including these variations in the calculation of CTV to PTV 
margins.  
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Purpose/Objective: Proton therapy has the potential to 
improve lung cancer therapy. Current studies have shown 
significantly better treatment plans for protons than for the 
conventional photon treatments, but the dose distribution is 
more sensitive to patient motion. The aim of this review was 
to investigate peer-reviewed studies of motion management 
in proton therapy of lung cancer. 
Materials and Methods: The PRISMA-guidelines for review-
articles was followed. Keywords used to perform a search in 
Google Scholar, PubMed and PubMed Central, were 'proton 
therapy', 'lung cancer', 'gating', '4DCT', 'tracking' and 'interplay 
effect'. Inclusion criteria were scientific articles in English, 
articles available in full text online and the topics covering 
motion management technique or motion effect 
simulations/measurements. The articles were categorized 
according to the topics as treatment planning strategies, 
beam strategies, gating, tracking, adaptive planning and no 
motion management technique.  
Results: 1017 articles were found of which 36 articles were 
included in the analysis (Figure 1). Out of these articles, 18 
articles studied the motion effect for scanned beams, while 
15 discussed the effect when using scattered beam (unknown 
beam was used in three cases), see Table 1. Included in the 
treatment planning strategy were different spot 
size/distance (when the scanned beam was used), treatment 
plan quality (level of homogeneity, beam angels etc.), 
fractionation as well as 4DCT-planning. With the help of a 
4DCT-scan one could evaluate the motion of the tumor and 
choose the correct corresponding margin. Approaches applied 
were to use the averaged CT of all phases, the maximum 
intensity projection of all phases, or single phases such as the 
mid-ventilation or the end-of-inhale. Beam strategies 
included rescanning and different scanning techniques, e.g. 
discrete or continuous scanning. The main purpose of these 
beam strategies was to minimize the interplay effect.  
 
 
Figure 1. The inclusion of articles according to the PRISMA-
statement. 
Table 1. The number of articles in each category. 
 
 
 
Conclusions: The presented motion management techniques 
are required to deal with intra- and interfractional 
uncertainties of proton therapy. Comparing studies and the 
effectiveness of the techniques presented is challenging 
because the authors report different dose metrics. Scanned 
and scattered beam dose distributions appear less sensitive 
for larger tumors and for tumors with less intra-fractional 
motion. Further investigations may reveal to what extent 
motion management techniques are necessary in proton 
therapy, and when to use a particular technique.  
   
 
 
 
 
